ACE2:连接肺癌和COVID-19的节点
Yan Liao1, Ying Zhang2, Houfeng Li2
1School of Anesthesiology, Naval Medical University Shanghai 200433, China.
American journal of cancer research
|May 10, 2024
概括
ангиотензин转化酶2 (ACE2) 在肺损伤和肺高血压中起着关键作用. 肺癌患者的ACE2升高增加了SARS-CoV-2感染的风险和严重程度.
科学领域:
- 肺部医学 肺部医学
- 传染性疾病 传染性疾病
- 在瘤学瘤学.
背景情况:
- ангиотензин转化酶2 (ACE2) 是ACE2-Ang (1-7)-Mas受体轴的组成部分,影响肺功能和炎症.
- ACE2有助于肺高血压,并作为冠状病毒的细胞受体,包括SARS-CoV-2.
- 肺癌患者呈现高ACE2水平,增加他们对SARS-CoV-2感染和严重结果的易感性.
研究的目的:
- 审查ACE2在肺中的病理生理作用.
- 检查SARS-CoV-2感染对肺功能,纤维化和炎症的影响.
- 探索肺癌,ACE2和SARS-CoV-2易感性之间的联系,包括治疗目标.
主要方法:
- 对ACE2现有研究的文献综述2.
- 临床研究和分子机制的分析.
- 对肺癌患者的SARS-CoV-2感染信息的综合.
主要成果:
- 强调了ACE2在正常肺生理中的双重作用,以及作为SARS-CoV-2的入口点.
- 患有较高ACE2水平的肺癌患者面临SARS-CoV-2的风险增加.
- 长期的COVID-19可以导致肺纤维化和慢性炎症.
结论:
- 在肺癌和SARS-CoV-2感染之间的相互作用中,ACE2是关键因素.
- 了解ACE2的作用对于管理肺癌患者感染后的肺部并发症至关重要.
- 在减轻与SARS-CoV-2相关的肺损伤方面,ACE2是一个潜在的治疗标.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
COPD: Pathogenesis and Clinical Features
263
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
263
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Pneumonia II: Pathophysiology
260
The pathophysiology of pneumonia involves the following steps:
260
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


